Meridian Launches TRU Block® ULTRA – A Powerful Immunoassay Interference Blocker September 5, 2017 Read More
Meridian Initiates Clinical Trials for New Neonatal Saliva CMV illumigene Test August 9, 2017 Read More
Meridian Bioscience Introduces the Expansion of Its ImmunoCard STAT!® Product Line August 8, 2017 Read More
Meridian Bioscience Reports Third Fiscal Quarter 2017 Operating Results, Including Non-Cash Goodwill Impairment Charge,Declares Regular Cash Dividend, and Reaffirms Fiscal 2017 Guidance Excluding the Effect of Goodwill Impairment Charge July 27, 2017 Read More
Meridian Announces Wholly Foreign Owned Enterprise (WFOE) Office in Beijing, China July 20, 2017 Read More
Meridian Bioscience Comments on Recent FDA Matters Related to Magellan Diagnostics June 30, 2017 Read More
Meridian Bioscience, Inc. Expects to Report Third Quarter Fiscal 2017 Operating Results on Thursday, July 27, 2017 June 28, 2017 Read More
